Equities

Hikma Pharmaceuticals PLC

HIK:LSE

Hikma Pharmaceuticals PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,540.00
  • Today's Change-12.00 / -0.77%
  • Shares traded1.15m
  • 1 Year change-32.87%
  • Beta1.1634
Data delayed at least 20 minutes, as of Feb 06 2026 14:55 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments213229292
Total Receivables, Net973873841
Total Inventory986891776
Prepaid expenses737274
Other current assets, total183516
Total current assets2,2632,1001,999
Property, plant & equipment, net1,3261,1411,081
Goodwill, net382388389
Intangibles, net774712735
Long term investments626552
Note receivable - long term141823
Other long term assets------
Total assets5,1334,6804,471
LIABILITIES
Accounts payable358309291
Accrued expenses266243171
Notes payable/short-term debt214675
Current portion long-term debt/capital leases63211573
Other current liabilities, total701626467
Total current liabilities1,9781,3391,077
Total long term debt6531,0301,135
Total debt1,3061,1911,283
Deferred income tax182519
Minority interest111113
Other liabilities, total1637792
Total liabilities2,8232,4822,336
SHAREHOLDERS EQUITY
Common stock404040
Additional paid-in capital282282282
Retained earnings (accumulated deficit)2,3992,1952,129
Treasury stock - common(37)----
Unrealized gain (loss)------
Other equity, total(374)(319)(316)
Total equity2,3102,1982,135
Total liabilities & shareholders' equity5,1334,6804,471
Total common shares outstanding222221220
Treasury shares - common primary issue131313
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.